Backgroud Information regarding the epidemiological background of Bickerstaff brainstem encephalitis (BBE) is limited.
Methods We conducted a nationwide survey of BBE in the Japanese population in two steps: the first aimed to identify patients with brainstem encephalitis for the specified 3 year period and the second to evaluate whether the clinical picture met our diagnostic criteria for BBE.
Results The number of patients with brainstem encephalitis was estimated as 704 (95% CI 478 to 930) over the 3 years. The annual onset of BBE was roughly estimated as 100 cases, which accounted for 43% of brainstem encephalitis. BBE was slightly male predominant and often young onset. Among brainstem encephalitis patients, BBE was characterised by antecedent infectious symptoms, oropharyngeal palsy and sensory disturbance at the distal extremities with absent or decreased tendon reflexes, in addition to a triad of symptoms (external ophthalmoplegia, ataxia and impaired level of consciousness) and shorter duration to the peak, with good outcome. Anti-GQ1b antibodies were present in 75% of cases. Several BBE patients with atypical clinical features or without anti-GQ1b antibodies were also identified. These cases often had marked CSF pleocytosis, abnormal brain MRI findings and a longer duration to peak symptoms, sometimes with considerable residual deficits.
Conclusions BBE is a rare disorder but accounts for a major proportion of brainstem encephalitis. BBE consists of typical and atypical cases. Typical BBE has similar neurological and serological features to Fisher syndrome and shows good recovery whereas atypical BBE is characterised by delayed recovery, negative anti-GQ1b antibodies, and abnormal CSF and brain MRI findings with other possible pathogeneses.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding This work was supported by a research grant for Bickerstaff Brainstem Encephalitis (to MK, SK, YN and TKa) from the Ministry of Health, Labour and Welfare of Japan, by a research grant for neuroimmunological diseases (to SK, Tko and TKa) from the Ministry of Health, Labour and Welfare of Japan and by a Grant-in-Aid for Scientific Research (C) (KAKENHI 20590446 to MK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Competing interests None.
Ethics approval This study was conducted with the approval of the institutional ethics committee at Yamaguchi University Hospital.
Provenance and peer review Not commissioned; externally peer reviewed.